References
- KyleRATherneauTMRajkumarSVPrevalence of monoclonal gammopathy of undetermined significanceN Engl J Med2006354131362136916571879
- RajkumarSVKyleRATherneauTMSerum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significanceBlood2005106381281715855274
- GregersenHMadsenKMSørensenHTSchønheyderHCIbsenJSDahlerupJFThe risk of bacteremia in patients with monoclonal gammopathy of undetermined significanceEur J Haematol19986121401449714528
- KristinssonSYTangMPfeifferRMMonoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based studyBlood2010116152651265520610813
- KristinssonSYPfeifferRMBjörkholmMArterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based studyBlood2010115244991499820299513
- GregersenHNørgaardMSeverinsenMTEngebjergMCJensenPSørensenHTMonoclonal gammopathy of undetermined significance and risk of venous thromboembolismEur J Haematol201186212913420942842
- GregersenHJensenPGislumMJørgensenBSørensenHTNørgaardMFracture risk in patients with monoclonal gammopathy of undetermined significanceBr J Haematol20061351626716925792
- KristinssonSYTangMPfeifferRMMonoclonal gammopathy of undetermined significance and risk of infections: a population-based studyHaematologica201297685485822180421
- SorensenHTSabroeSOlsenJA framework for evaluation of secondary data sources for epidemiological researchInt J Epidemiol19962524354429119571
- FrankLEpidemiology. When an entire country is a cohortScience200028754622398239910766613
- AndersenTFMadsenMJørgensenJMellemkjaerLOlsenJHThe Danish National Hospital Register. A valuable source of data for modern health scienceDan Med Bull199946326326810421985
- International Myeloma Working GroupCriteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working GroupBr J Haematol2003121574975712780789
- GregersenHMellemkjaerLIbsenJSCancer risk in patients with monoclonal gammopathy of undetermined significanceAm J Hematol20006311610602159
- CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
- RagoAGrammaticoSZaTPrognostic factors associated with progression of smoldering multiple myeloma to symptomatic formCancer2012118225544554922786730
- BerensonJRAndersonKCAudellRAMonoclonal gammopathy of undetermined significance: a consensus statementBr J Haematol20101501283820507313
- ElisARadnayJShapiroHItzhakyDManorYLishnerMShould bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?Isr Med Assoc J200681284084217214099
- BerensonJRYellinOMonoclonal gammopathy of undetermined significance: why identification of these patients and assessment of their skeletons is importantClin Lymphoma Myeloma20099431131519717382
- GhobrialIMAre you sure this is Waldenstrom macroglobulinemia?Hematology Am Soc Hematol Educ Program2012201258659423233639